This oncology-focused biotech, advancing multiple clinical-stage therapeutics, just reported a notable insider sale in recent ...
ORLANDO, FL / ACCESS Newswire / April 10, 2026 / RedChip Companies, an industry leader in investor relations, media, ...
Jacob Funds, a mutual fund company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Fund started the year optimistically, expecting fiscal and ...
StockStory.org on MSN
A look back at biotechnology stocks’ Q4 earnings: Incyte (NASDAQ:INCY) vs. the rest of the pack
Looking back on biotechnology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Incyte (NASDAQ:INCY) and its peers. The biotechnology industry is defined by its ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...
LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced it has filed its Annual Report on Form 10-K for the year ended ...
1.1a Congress must establish a National Biotechnology Coordination Office (NBCO) within the Executive Office of the President with a director, appointed by the President, who would coordinate ...
Historically, South San Francisco was known for meatpacking, steel production and shipbuilding, industries that long defined ...
View Lixte Biotechnology Holdings, Inc. LIXT stock quote prices, financial information, real-time forecasts, and company news from CNN.
Fees are Below Average compared to funds in the same category. Franklin Biotechnology Discovery Fund has an expense ratio of 1.01 percent. Risk is Above Average compared to funds in the same category ...
IBT's Ailsa Craig and Marek Poszepczynski give their key stock picks as companies move on from the science to commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results